SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is facing renewed attention as crypto market sentiment fluctuates between bullish technical signals and community debates over potential price consolidation. Investors are actively discussing the symbol's struggle to break key resistance levels while weighing its long-term viability against other emerging meme coins.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

The Direxion Daily Semiconductor Bear 3X Shares (SOXS) is seeing heavy social media volume as traders debate whether the semiconductor sector's record-breaking win streak is nearing a parabolic peak or represents an unbreakable AI-driven super cycle. Community members are actively sharing their high-conviction positions and frustration over the instrument's significant decay, while others continue to debate the timing of a potential sector-wide pullback.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is experiencing a parabolic, historic rally driven by persistent AI-sector demand and widespread institutional interest that has triggered consecutive daily gains. While the community is actively debating the sustainability of this bubble-like momentum versus potential imminent exhaustion, sentiment remains sharply divided between bulls expecting further record-breaking upside and bears positioning for a violent mean reversion.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as investors aggressively accumulate in anticipation of upcoming announcements and the project's featured presence at the XRP Las Vegas conference. Community sentiment remains polarized, with long-term holders emphasizing patience and potential utility-driven growth, while others debate the impact of volatility and market speculation.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

The community is actively discussing a potential breakout for PEPE as it struggles to maintain momentum above key resistance levels. Traders remain split between those bullish on future price discovery driven by market-wide meme sentiment and others skeptical of the asset's long-term volatility.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying as investors pile into the stock following confirmation of a significant order from Celestial AI, which was recently acquired by Marvell, fueling excitement about the company's role in the AI infrastructure supply chain. The community is actively discussing the stock's parabolic price action and its potential for a short squeeze, with many retail holders dismissing recent bearish short reports while eagerly anticipating potential partnerships with hyperscalers.

X-Energy, Inc. operates as an energy company The firm focuses on modular nuclear reactors and fuel technology for clean energy generation. The company was founded by Kam Ghaffarian and Eben Mulder on 2009 and is headquartered in Rockville, MD.

X-Energy Inc. - Ordinary Shares- Class A

X-energy Inc

X-energy is trending following its robust Nasdaq IPO, with investors actively debating its long-term potential as an Amazon-backed nuclear play positioned at the intersection of AI-driven power demand and industrial infrastructure. The community is focused on the stock's significant debut performance, comparisons to existing nuclear peers, and the strategic implications of high institutional interest despite the company being in a pre-operational phase.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently surging and trending as a major short squeeze candidate following the FDA's decision to lift clinical holds on its key heart disease trial, a move that fundamentally de-risks its gene-editing pipeline. The community is focused on the massive short interest and the potential for a significant rally as traders weigh this regulatory win against an upcoming Phase 3 readout for its hereditary angioedema therapy.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community doubles down on long-term conviction and utility building despite recent price volatility and sell pressure. Investors are actively discussing the project's pivot toward business management and AI-integrated tools while maintaining a 'WAGMI' mindset to hold through market consolidation.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending due to a major rotation into semiconductor stocks following strong CPU demand narratives and industry-wide gains, which has fueled a significant short squeeze. The community is actively debating whether this momentum represents a sustainable AI-driven S-curve or an overextended bubble reminiscent of past market cycles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Citi’s CFO in the earnings call this month had said that he expects to see headcount continue to trend downward.</li><li>Citigroup is reportedly expected to lay off more employees in March following a round of 1000 job cuts this month.&nbsp;</li><li>The new round of layoffs is expected to be announced after bonuses are paid, a report from Reuters News said.</li></ul>Citigroup will continue to cut more jobs in 2026, as part of its CEO’s reorganization efforts, a company spokesperson told Stocktwits on Thursday.&nbsp;“We will continue to reduce our headcount in 2026,” a company spokesperson said in an emailed response to Stocktwits’ query.&nbsp;“These changes reflect adjustments we’re making to ensure our staffing levels, locations and expertise align with current business needs; efficiencies we have gained through technology; and progress against our Transformation work, which is nearing target state,” the spokesperson added.&nbsp;Shares in the company were down 1.7% at the time of writing.&nbsp;<h2 class="st-heading-2">Cuts In March</h2>Citigroup is reportedly expected to lay off more employees in March following a round of 1,000 job cuts this month.&nbsp;The new round of layoffs is expected to be announced after bonuses are paid, a report from Reuters News said, citing sources familiar with the matter.&nbsp;The March layoffs are likely to affect managing directors and senior employees across business lines and some senior managers have already been reassigned to different divisions to secure roles before headcount is reduced, the report added.&nbsp;<h2 class="st-heading-2">CEO’s Reorganization Efforts</h2>Citi’s CEO Jane Fraser has led the corporate reorganization efforts at the U.S. firm since taking up the role, in a bid to trim down management layers and fasten decision making.Citi’s Chief Financial Officer Mark Mason during its fourth quarter earnings call said that Citi's workforce shrank by 20,000 since 2022 and is now at 226,000 employees by the end of 2025.“We'll see that cost and headcount come down as we continue to improve productivity and implement tools like AI, we'd see an impact, or expect to see an impact on headcount. So, notwithstanding, insourcing and driving broader efficiency, I would expect to see headcount continue to trend downward,” he had said.&nbsp;<h2 class="st-heading-2">Recent Earnings</h2>Citi reported higher fourth quarter (Q4) profit buoyed by rebound in dealmaking activities, that beat analyst estimates. On an adjusted basis, Citi reported a ​profit of $1.81 per share during the quarter, compared with analysts' average estimate of $1.67, according to data from fiscal.ai.&nbsp;Citi’s investment banking fees in Q4 rose 35% to $1.29 billion, up from $951 million from a year-ago quarter.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around Citi trended in ‘bearish’ territory amid ‘low’ message volume.&nbsp;Shares in the bank have risen 39% over the past 12 months.&nbsp; &nbsp;

A Citibank logo is displayed outside their bank on February 28, 2025 in San Diego, California. (Photo by Kevin Carter/Getty Images)

Citi Will Cut More Jobs In 2026 As Part Of CEO’s Reorganization Efforts

A Citigroup spokesperson told Stocktwits that layoffs reflect adjustments Citi is making to ensure its staffing levels, locations and expertise align with current business needs. 

Equity

A Citigroup spokesperson told Stocktwits that layoffs reflect adjustments Citi is making to ensure its staffing levels, locations and expertise align with current business needs. 


<ul class="summary-bullets"><li>“We will continue to reduce our headcount in 2026”, the company said, as per the report.&nbsp;</li><li>CEO Jane Fraser has taken the corporate reorganization efforts at the U.S. firm since taking up the role</li><li>Citigroup is planning to report results on Wednesday and inform its staff of their bonuses for 2025. &nbsp;</li></ul>U.S. banking giant Citigroup is reportedly cutting 1000 jobs this week as part of its CEO Jane Fraser's cost-cutting efforts.The job cuts are part of the bank's plan announced two years ago to reduce staff by 20,000 before the end of 2026, according to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2026-01-12/citi-to-cut-about-1-000-jobs-this-week-as-fraser-trims-costs">report</a> from Bloomberg News that cited people familiar with the matter.&nbsp;Fraser has taken the corporate reorganization efforts at the U.S. firm since taking up the role, in a bid to trim down management layers and fasten decision making.&nbsp;“We will continue to reduce our headcount in 2026”, the company said, as per the report. It further added that these changes reflect adjustments the company is making to ensure staffing levels and expertise align with current business needs.&nbsp;<h2 class="st-heading-2">FY25 Results On The Horizon</h2>Citigroup is planning to report results on Wednesday and inform its staff of their bonuses for 2025.&nbsp;The company is expected to post a revenue of $20.5 billion for the fourth quarter (Q4) as per the data from Fiscal.ai. It is also expected to post a profit of $1.73 per share.&nbsp;<h2 class="st-heading-2">Improving Control Issues</h2>Citigroup has been improving its oversight and control deficiencies in its business. Last month, the Federal Reserve told the firm that it has closed formal notices requiring the bank to fix trading risk management weaknesses, according to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/sustainability/boards-policy-regulation/us-fed-terminates-citi-notices-that-demanded-bank-improve-risk-controls-sources-2025-12-17/">report</a> from Reuters News.The Fed in 2023 had issued notices to Citi to address three so-called Matters Requiring Immediate Attention, or MRIAs, identifying problems relating to how the bank calculates and manages the risks of its trading partners and sets aside capital to cushion potential losses on those trades, the report added.&nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around <a href="https://stocktwits.com/symbol/C">C</a> trended in ‘neutral’ territory amid ‘high’ message volume.&nbsp;Shares in Citigroup have risen nearly 66% over the past year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

Chief executive officer of Citigroup Jane Fraser visits FOX Business Network's "Mornings With Maria" at Fox Business Network Studios on May 29, 2025 in New York City. (Photo by John Lamparski/Getty Images)

US Banking Giant Citigroup To Cut 1,000 Jobs This Week: Report

The job cuts are part of the bank's plan announced two years ago to reduce staff by 20,000 before the end of 2026, Bloomberg News report said. 

<ul class="summary-bullets"><li>Piper Sandler downgraded ALEX stock to ‘Neutral’ from ‘Overweight’ and kept the price target unchanged at $21.</li><li>Alexander &amp; Baldwin announced on Monday that it would go private in a deal worth $2.3 billion.&nbsp;</li><li>The company will be acquired by a MW Group joint venture for $21.20 per share by the first quarter of 2026, the company said in a statement.&nbsp; &nbsp;</li></ul>Shares of Alexander &amp; Baldwin (ALEX) rallied over 38% on Tuesday morning after the announcement of the $2.3 billion take-private deal.The company’s outstanding shares will be acquired at $21.20 per share by a joint venture formed among MW Group, Blackstone Real Estate, and DivcoWest, expected to close by the first quarter of 2026. The all-cash deal represents a 40% premium to the company’s closing price as of Dec. 8, 2025.&nbsp;In addition, Alexander &amp; Baldwin announced a fourth-quarter (Q4) 2025 dividend of $0.35 per share, payable on January 8, 2026.&nbsp;<h2 class="st-heading-2">Street Action</h2>Meanwhile, Piper Sandler downgraded ALEX to ‘Neutral’ from ‘Overweight’ before, while keeping the price target intact at $21, as cited on TheFly. Piper said that it has revised its rating following the announcement and does not expect a competing bid to emerge.“Today, we are taking an important step toward our long-term vision for A&amp;B as stewards of Hawai'i's premier commercial real estate. As a private company supported by the deep real estate expertise and experience of our new ownership group, A&amp;B will have greater capacity to serve its tenants and communities,” President and CEO Lance Parker said.&nbsp;Alexander &amp; Baldwin is the only publicly traded real estate investment trust focused solely on Hawaiian commercial real estate. The company owns about four million square feet of commercial space in Hawai'i.&nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around ALEX jumped from ‘neutral’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:1276/154;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_09_at_8_30_30_PM_png_5f7959ea10.webp" alt="On Stocktwits, retail sentiment around ALEX jumped from ‘neutral’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels." width="1276" height="154"></figure>Shares of ALEX have climbed over 18% in the past year and returned almost 30% in the last five years.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com&nbsp;

Generic Image of Office Space (Photo by Fairfax Media via Getty Images via Getty Images)

Alexander & Baldwin Shares Shoot Through The Roof After $2.3B Take Private Deal – This Firm Has Downgraded The Stock

Shares of ALEX surged over 38% in pre-market trading while Piper Sandler downgraded the stock. 

Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries (TEVA), announced on Thursday that the U.S. Food and Drug Administration has approved a generic version of the Liraglutide injection known as Saxenda.Liraglutide Injection is a glucagon-like peptide 1 (GLP-1) receptor agonist indicated to reduce excess body weight and maintain weight reduction long-term in adults as well as pediatric patients aged 12 years and older with body weight greater than 60 kg and obesity. The drug is to be used in combination with a reduced-calorie diet and increased physical activity.“With this approval, and by launching a generic for Saxenda (liraglutide injection), we will provide patients in the U.S. the first ever generic GLP-1 product specifically indicated for weight loss,” <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.tevapharm.com/news-and-media/latest-news/teva-announces-fda-approval-and-launch-of-generic-saxenda-liraglutide-injection--first-generic-glp-1-/">said</a> Ernie Richardsen, Head of U.S. Commercial Generics at Teva. He added that it marks an important addition to the company’s generics portfolio.Saxenda, Novo Nordisk’s older obesity drug, had annual sales of $165 million as of June 2025, the company said. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/TEVA">TEVA stock</a> trended within ‘neutral’ territory over the past 24 hours, while message volume remained at ‘high’ levels.<figure class="image"><img style="aspect-ratio:625/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_28_at_9_52_29_AM_png_ba7ec14e95.webp" alt="TEVA's Sentiment Meter and Message Volume as of 9:52 a.m. ET on Aug. 28, 2025 | Source: Stocktwits" width="625" height="64"><figcaption>TEVA's Sentiment Meter and Message Volume as of 9:52 a.m. ET on Aug. 28, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed surprise that the stock is not trading higher despite the approval.<stembedurl>https://stocktwits.com/RemitTekram/message/626845403</stembedurl>Another user sounded skeptical, saying that the stock would probably end the day in the red despite “explosive news.”<stembedurl>https://stocktwits.com/NoTradeAnymore/message/626842741</stembedurl>In the second quarter, Teva recorded revenue of $4.2 billion and adjusted and diluted earnings per share of $0.66. Generics product revenues in the U.S., however, fell 6% to $961 million, due to lower revenues from Lenalidomide capsules, the generic version of Revlimid, and Liraglutide injection 1.8mg, an authorized generic of Victoza, primarily driven by increased competition.TEVA stock is down 19% this year and approximately 3% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/lakeshore-biopharma-receives-revised-proposal-to-acquire-company/chs6JRRRdmm">LakeShore Biopharma Receives Revised Proposal To Acquire Company</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

A very overweight woman with swollen feet stands on a scale that reads 145.1 kilograms. Overweight and obesity are increasing at a rapid pace worldwide. Photo: Pia Bayer/dpa (Photo by Pia Bayer/picture alliance via Getty Images)

This Pharma Stock Is Down 19% In 2025 But Just Received An ‘Explosive News’ – Find Out More

The company’s U.S. affiliate announced that the U.S. Food and Drug Administration has approved a generic version of Liraglutide injection, known as Saxenda.

Current Price	$22.12
Prev Close	$22.10
Open	$22.15
Dividend Yield	N/A
50-Day Moving Average	$22.02
Beta	N/A
Avg. Volume	18,466.33
PE Ratio	N/A

52-Week High	$22.55
52-Week Low	$20.13
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

IYLD
iShares Morningstar Multi-Asset Income ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IYLD News

IYLDiShares Morningstar Multi-Asset Income ETF